Victor Kovac

Victor Kovac

Auto-generated profile, based on publicly available information

Victor Kovac

Division of Infectious Diseases, Brigham and Women's Hospital , Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2025 in JHLT Open
Verified
Journal Article
Open access
ACAntonio Coppolino
Antonio Coppolino
RMRie Maurer
Rie Maurer
EWElla Woehl
Ella Woehl
ECErin M. Connolly
Erin M. Connolly
ECElene Chamberlin
Elene Chamberlin
AWAnn E. Woolley
Ann E. Woolley
Bronchial stenosis is a known complication after lung transplantation, but risk factors remain incompletely understood. We identified predictors of bronchial stenosis requiring bronchoscopic intervention, with a focus on post-transplant bacterial infections, and its impact on clinical outcomes. We conducted a retrospective cohort study of 342 adult lung transplant recipients at a single center between 2017 and 2023. Bronchial stenosis was defined as localized airway narrowing requiring intervention. Clinical, perioperative, and infectious variables—censored to precede the onset of stenosis—were analyzed using univariate and multivariable logistic regression. Outcomes included survival, acute cellular and antibody-mediated rejection, and chronic lung allograft dysfunction (CLAD). Thirty-four patients (9.9%) developed bronchial stenosis requiring intervention. Multivariable analysis identified male sex (OR: 2.77, 95% CI: 1.13–6.79, p = 0.0261), pulmonary graft dysfunction (PGD) (OR: 3.45, 95% CI: 1.23–9.69, p = 0.0190), length of index hospitalization (OR: 1.01, 95% CI: 1.00–1.02, p = 0.0479), and any positive post-transplant bacterial respiratory culture—prior to onset of stenosis—(OR: 3.97, 95% CI: 1.67–9.48, p = 0.0019) as independent risk factors. Pneumonia and colonization with Pseudomonas aeruginosa or other gram-negatives were strongly associated with stenosis, while Staphylococcus aureus infections and colonization were not. Bronchial stenosis did not significantly impact survival, rejection, or CLAD incidence. Bronchial stenosis following lung transplantation is associated with PGD and bacterial airway infections, particularly Pseudomonas species or other gram negatives. These findings support an association between early gram-negative bacterial airway infections and bronchial stenosis and highlight the need for infection prevention and further prospective studies to clarify causal mechanisms and guide targeted interventions.

15 May 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
TATejas S Athni
Tejas S Athni
CSCarolyn B Strauch
Carolyn B Strauch
VKVictor Kovac
Victor Kovac
EAEsther Arbona-Haddad
Esther Arbona-Haddad
IVInia Perez Villa
Inia Perez Villa
ASAmy C Sherman
Amy C Sherman
Background: Invasive fungal sinusitis (IFS) profoundly impacts individuals with hematological malignancies, with rapid progression and high mortality rates. In an evolving therapeutic landscape, outcomes for patients with hematological malignancies who develop IFS warrant further evaluation. Methods: We performed a descriptive case series and retrospective review of patients with hematologic malignancies who developed proven IFS (per European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria) between 2005 and 2024 at a tertiary academic center. Clinical data and outcomes were collected from electronic medical records. Statistical analyses included Fisher exact tests, t tests, or Wilcoxon rank-sum tests. Kaplan-Meier curves were used to estimate survival probability, and log-rank tests were compared across groups. Results: Thirty-one patients with confirmed IFS were identified. Most patients had acute myeloid leukemia (61.3%) and received cytotoxic chemotherapy (96.8%). Targeted oncologic therapies included BCL2 inhibitors (29.0%), FLT3 inhibitors (19.4%), antibody-based therapies (12.9%), BTK inhibitors (6.4%), and antibody–drug conjugates (6.4%). The most common fungal isolates were Aspergillus (22.6%), Fusarium (16.1%), and Rhizopus (9.7%). Amphotericin B (96.8%) and voriconazole (71.0%) were frequently used, and newer antifungals included isavuconazole (38.7%), olorofim (3.3%), and fosmanogepix (3.3%). Necrotic tissue (45.2%) and mucosal thickening (87.1%) were common on sinonasal endoscopy and computed tomography scan, respectively. Orbital (25.8%) and intracranial (9.7%) extension occurred in a minority. Most patients underwent functional endoscopic sinus surgery (80.6%). Serum fungal biomarkers were infrequently positive, with (1,3)-ß-D-glucan in 19.4% and galactomannan in 9.7%. Overall mortality was 71.0% at the end of the study period, with a median survival (interquartile range) of 101 (21–299) days. Mortality was 22.6% at 1 month, 25.8% at 2 months, 32.3% at 3 months, 41.9% at 6 months, 54.8% at 1 year, 58.1% at 2 years, and 64.5% at 3 years. Conclusions: Despite novel therapies and aggressive surgical interventions, patients with IFS had high mortality.

28 April 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
VKVictor Kovac
Victor Kovac
SHSarah P Hammond
Sarah P Hammond
NINicolas C Issa
Nicolas C Issa
ALAlexis Liakos
Alexis Liakos
JLJessica S Little
Jessica S Little
AWAnn E Woolley
Ann E Woolley
Invasive fusariosis (IF) is a rare but aggressive infection seen in immunocompromised patients that often exhibits elevated minimum inhibitory concentrations (MICs) to antifungal drugs, making the optimal therapeutic remains unknown. We identified all cases of IF between January 2015 and April 2024 and collected patient characteristics, including clinical presentation, therapy, and 12-week outcomes, as well as organism species identification and susceptibility testing. Twenty-one patients were diagnosed with either proven (n = 14) or probable (n = 7) IF. The mean age was 60 years and 71% were male. Hosts had hematologic disorders in 71% of which 80% had acute leukemia. Seventy-three percent were neutropenic at the time of IF diagnosis and 40% had received allogeneic stem cell transplantation. Infections were localized in 57% and disseminated in 43%. Skin was the most common site of involvement (67%), followed by pulmonary (42%) and sinus (21%). The most common species was Fusarium solani complex (38%). Susceptibility testing was performed on 81% of isolates. MICs were ≥4 µg/mL for mold-active triazoles in 94% and ≥1 µg/mL for terbinafine in 65%. The most common definitive regimens were a triazole plus terbinafine (62%) and triazole monotherapy (19%). Surgical debridement was performed in 52%. Seventy-six percent of patients survived to 12 weeks. Fifty-seven percent achieved complete responses, 29% partial responses, and 14% failed to respond to therapy at 12 weeks. Mortality in patients with IF is high. Despite elevated MICs, clinical responses to triazole antifungals with or without the addition of terbinafine are observed.

1 September 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
AHAlejandro De La Hoz
Alejandro De La Hoz
VKVictor Kovac
Victor Kovac
AWAnn E Woolley
Ann E Woolley
NINicolas C Issa
Nicolas C Issa
ALAlyssa Letourneau
Alyssa Letourneau
JLJessica S Little
Jessica S Little
Diagnosis of chronic disseminated candidiasis (CDC) is frequently delayed because clinical manifestations are nonspecific and conventional diagnostic tests have limited sensitivity. We describe a series of 19 CDC cases in which plasma microbial cell-free DNA sequencing was performed due to diagnostic uncertainty. Results influenced antifungal management in most cases.

26 September 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
SGSimran Gupta
Simran Gupta
TATejas S Athni
Tejas S Athni
EAEsther Arbona-Haddad
Esther Arbona-Haddad
IVInia Perez Villa
Inia Perez Villa
ALAlexis Liakos
Alexis Liakos
ASAmy C Sherman
Amy C Sherman
Among 132 people with hematologic malignancies and invasive fungal disease, invasive fungal sinusitis was associated with greater dissemination, lower biomarker sensitivity, more diverse fungal pathogens, and higher rates of chronic rhinosinusitis and sinonasal defects than invasive fungal pneumonia. These findings suggest distinct clinical syndromes with different risk factors and diagnostic considerations.